Targeting Tau to Treat Clinical Features of Huntington's Disease.
Saved in:
| Title: | Targeting Tau to Treat Clinical Features of Huntington's Disease. |
|---|---|
| Authors: | Masnata M; Centre de Recherche du CHU de Québec, Axe Neurosciences, Québec, QC, Canada.; Département de Psychiatrie & Neurosciences, Université Laval, Québec, QC, Canada., Salem S; Centre de Recherche du CHU de Québec, Axe Neurosciences, Québec, QC, Canada.; Département de Médecine Moléculaire, Université Laval, Québec, QC, Canada., de Rus Jacquet A; Centre de Recherche du CHU de Québec, Axe Neurosciences, Québec, QC, Canada.; Département de Psychiatrie & Neurosciences, Université Laval, Québec, QC, Canada., Anwer M; Centre de Recherche du CHU de Québec, Axe Neurosciences, Québec, QC, Canada.; Département de Psychiatrie & Neurosciences, Université Laval, Québec, QC, Canada., Cicchetti F; Centre de Recherche du CHU de Québec, Axe Neurosciences, Québec, QC, Canada.; Département de Psychiatrie & Neurosciences, Université Laval, Québec, QC, Canada.; Département de Médecine Moléculaire, Université Laval, Québec, QC, Canada. |
| Source: | Frontiers in neurology [Front Neurol] 2020 Nov 19; Vol. 11, pp. 580732. Date of Electronic Publication: 2020 Nov 19 (Print Publication: 2020). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101546899 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2295 (Print) Linking ISSN: 16642295 NLM ISO Abbreviation: Front Neurol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
